Presentation Curioso

download Presentation Curioso

of 31

Transcript of Presentation Curioso

  • 7/30/2019 Presentation Curioso

    1/31

    Design and implementation of aDesign and implementation of a

    realreal--time surveillance system fortime surveillance system for

    adverse events usingadverse events using

    cell phones in Perucell phones in Peru(Cell(Cell--PREVEN)PREVEN)

    Walter H. Curioso, MD, MPHcWalter H. Curioso, MD, MPHc

    2005. All rights reserved. Walter H. [email protected]

    School of Public Health and Community Medicine

    University of Washington

  • 7/30/2019 Presentation Curioso

    2/31

    Walter H. Curioso, M.D. Dr. Walter H. Curioso is a physician

    from the Universidad PeruanaCayetano Heredia, Peru and currentlya Master in Public Health's candidate

    at the University of Washington,Seattle.

    He has more than thirty publicationsin the following fields: healthinformatics and informationtechnology, evidence-basedmedicine, public health in developingcountries and clinical medicine.

    Dr. Curioso is an e-health consultant

    for international and privateorganizations, including the designand implementation of informationsystems and technology in publichealth and health care organizations.

    http://www.waltercurioso.comhttp://students.washington.edu/wcurioso/

  • 7/30/2019 Presentation Curioso

    3/31

    Estimated new cases of curable

    STI* among adults, 1999

    Western Europe

    17 million

    Western Europe17 million

    Eastern Europe and Central Asia

    22 million

    Eastern Europe and Central Asia

    22 million

    North Africa & Middle East

    10 million

    North Africa & Middle East

    10 million South & South-East Asia

    151 million

    South & South-East Asia151 million

    Australasia

    1 million

    Australasia1 million

    Sub-Saharan Africa

    69 million

    Sub-Saharan Africa

    69 million

    * gonorrhoea, chlamydial infection, syphilis and trichomoniasis

    Source: WHO. http://www.who.int/docstore/hiv/GRSTI/pdf/figure02.pdf

    North America

    14 million

    North America

    14 million

    Latin America &

    The Caribbean

    38 million

    Latin America &

    The Caribbean38 million

    East Asia & Pacific

    18 million

    East Asia & Pacific

    18 million

    Global total: 340 million

  • 7/30/2019 Presentation Curioso

    4/31

    Adapted from Eysenbach 2003

    Population Health Technology

  • 7/30/2019 Presentation Curioso

    5/31

    Evaluation of information technologies in Peru. 2004

    Cell Phone Technology

    Growth

    rate

  • 7/30/2019 Presentation Curioso

    6/31

    http://www.yachay.com/especiales/cabinas/2ba.htm

    Internet in Peru

    Evolution of public booths(Cabinas publicas)

    417

    1371

    1973

    2600

    3600

    0

    500

    1000

    1500

    2000

    2500

    3000

    3500

    4000

    Total number

    1999 2000 2001 2002 2003

    Year

  • 7/30/2019 Presentation Curioso

    7/31

    Internet in Peru

    Public booths / Internet cafes(Cabinas publicas)

    http://www.yachay.com/especiales/cabinas/2ba.htm

  • 7/30/2019 Presentation Curioso

    8/31

    Background

    System that combines the Internetand the telephone to collect and

    transmit data. Health professionals can enterreports in real time using a fixedphone line or a cell phone -.

    Authorized users log on and followsimple instructions on a card or asimple voice-prompted menu andenter information about adverse

    events. They can attach additional

    information in voice files.

    http://www.voxiva.net/about.html

  • 7/30/2019 Presentation Curioso

    9/31

    Background We implemented the system to collect data from an existing national

    urban-community randomized trial of routine presumptive periodictreatment of bacterial vaginosis called PREVEN.

    One of the target components is the female sex workers (FSW) inwhich a mobile team treats preventively trichomonasand bacterialvaginosis with Metronidazole; and screens and treat Neisseriagonorrheaand Chlamydia trachomatis.

    http://www.upch.edu.pe/faspa/preven/

    Mobile teamFSW

    Nurse or obstetrician Peer educator

  • 7/30/2019 Presentation Curioso

    10/31

    Cell-PREVEN Project

    Enter data of FSW in real time

    Surveillance system for adverse events PREVEN

  • 7/30/2019 Presentation Curioso

    11/31

    Multicentric

    Piura

    Huanuco

    Chincha

  • 7/30/2019 Presentation Curioso

    12/31

  • 7/30/2019 Presentation Curioso

    13/31

    Consolidationin Level 2

    CentralLevel:

    Analysisand

    decision-

    making

    Consolitationin Level 3

    Datacollection

    atcommunity

    level

    Analysis andProcess of theinformation

    Analysis andProcess of the

    Information

    Paper based system

    Days, weeks or months (collection andtransmission of data)

  • 7/30/2019 Presentation Curioso

    14/31

    Central Level:Analysis and

    decision-making

    Datacollection

    atcommunity

    level

    Consolidacinen Nivel 2

    Consolidacinen Nivel 3

    Anlisis yProcesamiento de

    la informacin

    Anlisis y

    Procesamiento dela informacin

    Seconds

    9 Implementation of asurveillance system

    9 Enhanced ability to

    manage clinical STDprograms

    9 Real time access to data.

    9 Transparency,

    accountability and dataprivacy.

    9 First-hand information

    9 Opportune

    decision-making based ontimely information

    9 Improved onitoring atfacility level

    Cell phone system

  • 7/30/2019 Presentation Curioso

    15/31

    Information isavailable inmediatelyand timely processed

    for multiple needs

    Queries on demand

    Real time warnings via text messages

    Real time warnings via E-mail

    Information isreceived at Voxiva

    hub (Lima) andstored in a secureweb-based database

    Data of adverseevents is collecting

    and sending inreal time on field

  • 7/30/2019 Presentation Curioso

    16/31

    Any symptom

    Specific symptomsAdditional informationSatisfactionAnother report

    Any symptom

    Specific symptomsAdditional informationSatisfactionAnother report

    How it works?

  • 7/30/2019 Presentation Curioso

    17/31

    Training

    Training andmonitoring

    Technical support:telephone, cellphone, e-mail or

    even by chat (MSN)

  • 7/30/2019 Presentation Curioso

    18/31

  • 7/30/2019 Presentation Curioso

    19/31

  • 7/30/2019 Presentation Curioso

    20/31

    Users card

  • 7/30/2019 Presentation Curioso

    21/31

    Before . . .

  • 7/30/2019 Presentation Curioso

    22/31

    Now . . .

  • 7/30/2019 Presentation Curioso

    23/31

    Access: Demo call phone report

    Cdigo de Usuario 123456

    Clave de Usuario 12376

  • 7/30/2019 Presentation Curioso

    24/31

    Access: Demo call phone report

    La participante tuvo nuseas elprimer dia.

    Clave de participante 12376

  • 7/30/2019 Presentation Curioso

    25/31

    Technical support

    Technical support:24 hours / 7 days aweek

    through Voxiva

    http://www.voxiva.net/about.html

  • 7/30/2019 Presentation Curioso

    26/31

  • 7/30/2019 Presentation Curioso

    27/31

  • 7/30/2019 Presentation Curioso

    28/31

    ALERT PREVENALERT PREVENScreen example Alert:

    text message

  • 7/30/2019 Presentation Curioso

    29/31

    University of WashingtonSeattle.

    The Wellcome Trust

    Imperial College London Universidad Peruana Cayetano

    Heredia (School of PublicHealth: FASPA)Lima, Peru.

    VoxivaLima, Peru.

    Institutions involved

  • 7/30/2019 Presentation Curioso

    30/31

    My advisors:

    Ann Marie Kimball, MD, MPH Bryant Karras, MD

    King Holmes, MD, PhD

    Pablo Campos, MD, MPH

    Pamela Johnson, MD Francisco Rubio, MD

    Ernesto Gozzer, MD

    Special thanks to

  • 7/30/2019 Presentation Curioso

    31/31

    Gracias !Gracias !

    Cell phone project Web page: http://www.prevenperu.org